Biotest
BIO.F
$45.86
Share price
-0.48%
Change (1 day)
2.78%
Change (1 year)
Categories
Revenue for Biotest (BIO.F)
Revenue in 2024 (TTM): $0.77 Billion USD
According to Biotest
's latest financial reports the company's current revenue (TTM 
) is $0.77 Billion USD. In 2023 the company made a revenue of $0.74 Billion USD an increase over the revenue in the year 2022 that were of $0.54 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Biotest from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | $0.77 B | 4.2% |
| 2023 | $0.74 B | 36.01% |
| 2022 | $0.54 B | -9.11% |
| 2021 | $0.59 B | 6.58% |
| 2020 | $0.56 B | 19.91% |
| 2019 | $0.46 B | -0.25% |
| 2018 | $0.47 B | 57.23% |
| 2017 | $0.29 B | -47.23% |
| 2016 | $0.56 B | -12.97% |
| 2015 | $0.65 B | -13.81% |
| 2014 | $0.75 B | 13.51% |
| 2013 | $0.66 B | 16.25% |
| 2012 | $0.57 B | -1.56% |
| 2011 | $0.58 B | 17.53% |
| 2010 | $0.49 B | -20.06% |
| 2009 | $0.61 B |